Agios Pharmaceuticals, Inc. (0HB0.L)

USD 41.74

(-0.05%)

Inventory Summary of Agios Pharmaceuticals, Inc.

  • Agios Pharmaceuticals, Inc.'s latest annual inventory in 2023 was 19.07 Million USD , up 124.63% from previous year.
  • Agios Pharmaceuticals, Inc.'s latest quarterly inventory in 2024 Q3 was 26.42 Million USD , up 10.41% from previous quarter.
  • Agios Pharmaceuticals, Inc. reported annual inventory of 8.49 Million USD in 2022, down 0.0% from previous year.
  • Agios Pharmaceuticals, Inc. reported annual inventory of - USD in 2021, down 0.0% from previous year.
  • Agios Pharmaceuticals, Inc. reported quarterly inventory of 26.42 Million USD for 2024 Q3, up 10.41% from previous quarter.
  • Agios Pharmaceuticals, Inc. reported quarterly inventory of 23.07 Million USD for 2024 Q1, up 20.94% from previous quarter.

Annual Inventory Chart of Agios Pharmaceuticals, Inc. (2023 - 2012)

Historical Annual Inventory of Agios Pharmaceuticals, Inc. (2023 - 2012)

Year Inventory Inventory Growth
2023 19.07 Million USD 124.63%
2022 8.49 Million USD 0.0%
2021 - USD 0.0%
2020 - USD -100.0%
2019 7.33 Million USD 743.61%
2018 869 Thousand USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 1.00 USD 0.0%
2014 1.00 USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Inventory Comparison of Agios Pharmaceuticals, Inc.

Name Inventory Inventory Difference
Editas Medicine, Inc. - USD -Infinity%
Dynavax Technologies Corporation 53.29 Million USD 64.203%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 75.357%
Perrigo Company plc 1.14 Billion USD 98.328%
Illumina, Inc. 587 Million USD 96.75%
Thermo Fisher Scientific Inc. 5.08 Billion USD 99.625%
Iovance Biotherapeutics, Inc. 10.37 Million USD -83.918%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 99.771%
IQVIA Holdings Inc. - USD -Infinity%
Heron Therapeutics, Inc. 42.11 Million USD 54.7%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 99.261%
Unity Biotechnology, Inc. - USD -Infinity%
Waters Corporation 516.23 Million USD 96.305%
Biogen Inc. 2.52 Billion USD 99.245%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD -73.45%
Adicet Bio, Inc. - USD -Infinity%
Cara Therapeutics, Inc. 2.82 Million USD -576.214%
bluebird bio, Inc. 22.91 Million USD 16.768%
Esperion Therapeutics, Inc. 65.62 Million USD 70.931%
FibroGen, Inc. 41.56 Million USD 54.106%
Agilent Technologies, Inc. 1.03 Billion USD 98.15%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 78.601%
Amicus Therapeutics, Inc. 59.69 Million USD 68.045%
Myriad Genetics, Inc. 20.1 Million USD 5.095%
Viking Therapeutics, Inc. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 99.256%
Abeona Therapeutics Inc. -2.44 Million USD 880.524%
Mettler-Toledo International Inc. 385.86 Million USD 95.056%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 98.277%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 97.418%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD 32.89%
Atara Biotherapeutics, Inc. 9.7 Million USD -96.538%
Verastem, Inc. - USD -Infinity%
Nektar Therapeutics 16.1 Million USD -18.477%
Axsome Therapeutics, Inc. 15.13 Million USD -26.039%
Aclaris Therapeutics, Inc. - USD -Infinity%
Sarepta Therapeutics, Inc. 322.85 Million USD 94.092%
OPKO Health, Inc. 65.69 Million USD 70.964%
Exelixis, Inc. 17.32 Million USD -10.119%
Neurocrine Biosciences, Inc. 38.3 Million USD 50.193%
Corcept Therapeutics Incorporated 7.73 Million USD -146.779%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 12.02 Million USD -58.649%
Imunon, Inc. - USD -Infinity%
Blueprint Medicines Corporation 21.22 Million USD 10.116%
Insmed Incorporated 83.24 Million USD 77.085%
Halozyme Therapeutics, Inc. 127.6 Million USD 85.05%
TG Therapeutics, Inc. 39.82 Million USD 52.098%
Incyte Corporation 62.97 Million USD 69.707%
Emergent BioSolutions Inc. 328.9 Million USD 94.2%